These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 2178849)

  • 21. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents.
    Hsu A; Granneman GR; Bertz RJ
    Clin Pharmacokinet; 1998 Oct; 35(4):275-91. PubMed ID: 9812178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E
    Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.
    Barry M; Gibbons S; Back D; Mulcahy F
    Clin Pharmacokinet; 1997 Mar; 32(3):194-209. PubMed ID: 9084959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interactions between theophylline and other medication (Part I).
    Upton RA
    Clin Pharmacokinet; 1991 Jan; 20(1):66-80. PubMed ID: 1674242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic drug monitoring of phenytoin and valproic acid in critically ill patients at Windhoek Central Hospital, Namibia.
    Singu BS; Morrison H; Irengeya L; Verbeeck RK
    Afr J Lab Med; 2022; 11(1):1628. PubMed ID: 35937763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically significant carbamazepine drug interactions: an overview.
    Pippenger CE
    Epilepsia; 1987; 28 Suppl 3():S71-6. PubMed ID: 3319544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic drug interactions with propranolol.
    Wood AJ; Feely J
    Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic optimisation of anticonvulsant therapy.
    Thomson AH; Brodie MJ
    Clin Pharmacokinet; 1992 Sep; 23(3):216-30. PubMed ID: 1511537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of the clinical pharmacokinetics of oxcarbazepine.
    Flesch G
    Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interactions of antiepileptic drugs.
    Albright PS; Bruni J
    Can J Neurol Sci; 1984 May; 11(2):247-51. PubMed ID: 6428726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.
    Neuvonen PJ
    Clin Pharmacokinet; 1979; 4(2):91-103. PubMed ID: 378503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.